Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study.
JTO Clin Res Rep
; 2(2): 100114, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-34589984
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
JTO Clin Res Rep
Year:
2021
Type:
Article
Affiliation country:
China